Israeli Cancer Research Firm Vaxil Granted 9th Patent for Immunotherapy Treatment – P&T Community
|
Israeli Cancer Research Firm Vaxil Granted 9th Patent for Immunotherapy Treatment
P&T Community Provides Corporate Update. ISRAEL and TORONTO, May 03, 2018 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (TSX VENTURE:VXL), a cancer research biotechnology company focused on innovative immunotherapy treatments, has been granted a patent from the Indian Patent … |
